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ABSTRACT
Background. Endomyocardial biopsy (EMB) remains the gold standard for the diagno-
sis of graft rejection after heart transplantation (HT). Our purpose was to evaluate the rate
of complications of this invasive procedure.
Methods. This was a retrospective study of 175 patients, who were transplanted between
November 2003 and October 2010 and survived more than 1 month after surgery. We
evaluated the number of inconclusive EMB and described the incidence, nature, and
subsequent management of several complications associated with this procedure.
Results. Over a period of approximately 7 years, we performed 2217 EMB yielding 4972
specimens, namely, an average of 2.3 fragments per procedure. The majority of EMBs
(95.3%) were performed by the femoral approach. Only 12 EMB (0.57%) were inconclu-
sive. The overall complication rate was 0.71%. During puncture, one patient experienced
a vasovagal reaction and another one, a femoral artery false aneurysm. During the biopsy,
there was one case of cardiac perforation with tamponade, two cases of supraventricular
tachycardia, and three atrioventricular conduction abnormalities. In 19 patients, histolog-
ical analysis revealed chordal tissue, but only two patients developed mild tricuspid
regurgitation. We observed five cases of coronary artery fistulae. The clinical outcomes
were favorable in all cases.






fHEART FAILURE (HF) remains a major cause ofmortality, occurring within first 8 years after diagno-
sis among 80% of men and 70% of women under the age of
65 years.1 Indeed, despite therapeutic innovations, the
orbidity and mortality of advanced HF patients remain
igh. Therefore, when functional capacity is severely im-
aired, despite optimal medical therapy, orthotopic heart
ransplantation (OHT) appears, in most cases, to be the
nly option. In the United States, it is estimated that about
000 patients with advanced HF are transplanted each
ear.2 Restrictive selection criteria for donors and recipi-
nts, deeper understanding of immune system physiology,
evelopment of new immunosuppressive drugs, and better
urgical technique have improved the results. The experi-
nce of the Mayo Clinic reported above 90% 1-year survival
fter OHT and 5-year survival near 80%.2 The improved
outcomes of heart transplant patients over the past 30 years
is also a consequence of an increased ability to diagnose
rejection. In fact, the myocardial histological analysis re-
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1908eals several pathological findings that precede clinical
anifestations of allograft rejection, allowing an early
iagnosis.
Endomyocardial biopsy (EMB) is an invasive procedure,
erformed first by Sutton et al in 1956, using a transthoracic
eedle approach.3 In 1962, Sakakibara and Konno per-
ormed a transvenous EMB using the Konno bioptome.4
Later, in 1974, Caves and colleagues developed a technique
and instrumentation for percutaneous access, through the
internal jugular vein,5 allowing the procedure to be per-
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COMPLICATIONS OF ENDOMYOCARDIAL BIOPSY 1909formed with only local anesthesia. In 1984, the femoral vein
was described as an alternative vascular access.6 At present,
EMB is a routine procedure, remaining the gold standard to
monitor rejection among cardiac transplant patients. How-
ever, despite its growing applicability, the procedure is not
free of complications and limitations. This study sought to
define the safety of this invasive procedure through the
description and quantification of its complications.
PATIENTS AND METHODS
We included all 175 patients who underwent OHT from November
2003 through October 2010 and survived more than 1 month at a
single heart transplantation center. The follow-up varied from 1
month to approximately 7 years (mean  3.2  2.0).
Two interventional cardiologists performed 2.117 EMB accord-
ing to the following schedule: weekly for the first month, every 2
weeks for the second month, every 3 weeks for the next 4 months,
and every 2 months thereafter until the twelfth month. In addition
to EMB, patients also underwent right and left heart catheteriza-
tion and coronary angiography at 1, 3, and 5 years after OHT.
Another EMB was performed at 1.5 years. Additional biopsies
were obtained when there was a significant suspicion of rejection
despite adjustment of immunosuppressive therapy.
Procedures were performed without premedication. The femoral
and internal jugular veins were the only vascular access. The
puncture was performed under local anesthesia (1% lidocaine).
Using the Seldinger technique, we introduced a sheath (7-
French/90 cm). A Cordis bioptome (7-French/104 cm) was then
advanced slowly, through the sheath, to the apical segment of the
right side of the interventricular septum (IVS), using fluoroscopic
guidance. Myocardial specimens were sent to the pathology depart-
ment in 10% formalin.
All patients were continuously monitored during and after EMB.
A 12-lead electrocardiogram and a transthoracic echocardiogram
were performed before and after all the EMB procedures, respec-
tively.
The following demographic and patient characteristics were
analyzed: age, gender, etiology of HF, number of EMB procedures
and collected fragments, vascular access route, as well as type and
rate of complications, including death, cardiac perforation requir-
ing urgent pericardiocentesis or cardiac surgery, pneumothorax
and hemothorax, embolic stroke, arrhythmias, tricuspid regurgita-
tion (TR), or coronary artery fistula (CAF). We also reported
complications during the venous puncture.
RESULTS
We performed a OHT for end-stage congestive HF in 175
patients aged 4 to 72 years (mean  52.4  12.7 y). The
ajority were men (n  135; 77.1%). Dilated cardiomyop-
thy, the most prevalent clinical diagnosis, was identified in
pproximately half of the population (n  82, 46.8%), and
schemic cardiomyopathy in one-third of cases (n  58;
3.1%).
Over approximately 7 years, we performed 2117 EMB
rocedures. We preferentially used the femoral approach
n  2018; 95.3%); only 99 EMB were performed through
he right internal jugular vein. Among 4972 harvested
ragments (2–7 per procedure; mean  2.3), 4% did not
orrespond to myocardial tissue. The majority of the inad-quate fragments were fibrous tissue, probably from a
revious biopsy scar. We also observed samples of valvular
issue, fat, and thrombi. Among all of the EMB, only 12
ere considered inconclusive (0.57%), 89% revealed no
ejection but approximately 9% showed mild, 1.3% moder-
te, and three severe rejection episodes.
The cumulative incidence of complications was 0.71%
Table 1). During the puncture, a moderate vasovagal
eaction was documented in one patient who became pale,
weaty, and hypotensive. After fluid administration, he
xperienced total recovery. Another patient developed a
alse aneurysm of the right common femoral artery after the
eventh EMB, as confirmed by echo Doppler. Percutaneous
losure was achieved using intra-arterial injection of colla-
en and thrombin.
We did not identify any case of death related to the EMB
rocedure. Only one patient had a cardiac perforation
uring the third EMB. He complained of sudden chest pain,
yspnea, and severe hypotension. A transthoracic echocar-
iogram confirmed the presence of a pericardial effusion,
rovoking right diastolic collapse. Surgical drainage was
mmediately performed to stabilize the patient. There were
o recorded cases of hemothorax, pneumothorax, or em-
olic stroke.
Relatively to arrhythmias, we identified a single case of
trial fibrillation, which developed during the 15th EMB.
he patient remained asymptomatic with stable vital signs,
pontaneously converting to sinus rhythm, within 24 hours.
nother patient developed atrial flutter with a rapid ven-
ricular rate (150 beats per minutes) during the first EMB.
lthough he developed no symptoms or hemodynamic
nstability, a successful electrical cardioversion was per-
ormed after 12 hours. Abnormalities of atrioventricular
AV) conduction were documented in three patients. Two
ases developed transient second-degree block with 2:1
onduction. The third subject showed transitory complete
V block, during bioptome positioning. He previously




ardiac perforation 1 0.05
neumothorax 0 0
Hemothorax 0 0
Embolic stroke 0 0
Arrhythmias
Supraventricular tachycardia 2 0.09
Ventricular tachycardia 0 0
Conduction abnormalities
Complete heart block 1 0.05
Second degree AV block 2 0.09
False aneurysm 1 0.05
Vasovagal reaction 1 0.05
Coronary artery fistula 5 2.8










1910 SARAIVA, MATOS, GONÇALVES ET ALdisplayed left bundle branch block. None of the three
patients required therapeutic intervention.
Valvular tissue was identified during the histological
analysis in 19 transplant patients (10.8%). Subsequent
echocardiograms showed no development or worsening of
TR in the majority of cases. Only two patients developed
mild TR without increased pulmonary artery systolic pres-
sure.
CAF was identified in five patients (2.8%; Fig 1 and Fig
2). Except for one case, all were detected during coronary
angiography, performed routinely at 1 year after OHT. All
fistulae ended in the right ventricle and were small in size
and asymtomatic. A conservative approach was adopted in
all cases. After 2 years, one fistula maintained the same
angiographic appearance and another had completely re-
solved. The remaining three cases have not yet undergone
angiography for further comparative study. The histological
analysis of the fragments, collected prior to the detection of
the CAF, did not reveal the presence of dilated arterioles.
DISCUSSION
This survey describes complications of EMB. In contrast to
some groups, we preferably use the femoral vein for
vascular access. Previously published data have already
demonstrated that this approach allows an effective appro-
priate EMB in a greater percentage of cases compared to
the jugular access.7 Furthermore, the jugular vein is also
ssociated with a higher rate of complications, such as
neumothorax, hemothorax, carotid artery injury, and pa-
alysis of the recurrent laryngeal nerve.8 However, it is
ssociated with greater patient discomfort particularly dur-
Fig 1. Fistula between the anterior descending artery and the
right ventricle.ng walking and requires the patient to remain in bed for 2
ours postprocedure.
The average number of fragments collected per proce-
ure was less than that described in other published stud-
es,7,9,10 but the percentage of inappropriate specimens was
learly lower (4% vs 9%).7 In fact, sampling error is a real
problem associated with EMB, which may result in a missed
diagnosis or an underestimate of the severity of allograft
rejection. In this study, only 12 EMB procedures were
considered inconclusive. Despite collecting fewer speci-
mens than usual, almost all the EMB procedures allowed a
diagnosis of the absence or presence of rejection, and
among the latter instances, a quantification of its severity.
Therefore, despite the search for new noninvasive biomark-
ers, EMB remains the gold standard to monitor rejection in
cardiac transplant patients, with a diagnostic rate previously
reported to approach 100%.11,12
In this work, we have reported a low cumulative compli-
cation rate (0.71%). Deckers et al, in a prospective study of
546 EMB performed between 1982 and 1989, reported a
6% overall complication rate.10 In that series, the worse
result were probably due to the serious clinical state of the
patients, characterized by severe left ventricular dysfunc-
tion and increased filling pressures. The high average
number of collected specimens from each procedure (6  2
fragments) may also have contributed to the greater rate of
problems. Other series published in the 80s by the Mayo
Clinic and by the Hosenpud group also demonstrated
higher global complication rates: 4.4% and 14%, respec-
tively.13,14
The preferential use of the femoral approach, the restric-
tion of the EMB to the interventricular septum, the reduced
Fig 2. Fistula originating from the right ventricular branch of the































COMPLICATIONS OF ENDOMYOCARDIAL BIOPSY 1911all the fragments before sending them to the pathology
laboratory, and the large experience of our center may have
been responsible for our low complication rate. Only one
patient had a major complication associated with the EMB:
cardiac tamponade due to iatrogenic perforation of the
right ventricle (0.05%). Felker and colleagues described a
perforation rate of 0.31% among 323 prospectively studied
EMB.15 Frustaci and colleagues reported four cardiac
perforations (0.27%) among 1481 procedures.16
As in the study by Deckers et al,10 supraventricular
arrhythmias were the most common tachyarrhythmias. This
global arrhythmia incidence was higher than our observa-
tions (1.1% vs 0.2%). As previously described in the
literature, we also documented that patients with previous
left bundle branch block showed a higher risk of developing
complete AV block.17 The pressure exerted by the sheath or
he bioptome on the right IVS can damage the right branch
f the His bundle, producing complete block in patients
ith prior left bundle branch block. Therefore, continuous
onitoring of these patients is always recommended.
TR, the most common valvular abnormality in cardiac
ransplant patients, shows a prevalence ranging from 25%
o 45%.18,19 Its etiology is mulfactorial. We have encoun-
ered valve tissue in nearly 11% of our patients. Mielniczuk
nd colleagues reported a similar rate of valvular fragment
ollection (9.2%) among 205 EMB.20 Fiorelli et al reported
a much lower rate (3.2%),21 probably due to the use of
ransthoracic echocardiography guidance during the EMB
rocedures. EMB may have a direct impact on the devel-
pment of TR; however, the strength of this association
emains controversial. In our series, as had also been shown
y Fiorelli et al,21 there was no significant correlation
etween accidental chordal tissue biopsy and the develop-
ent of serious TR.
The incidence of CAF among our population was higher
han that observed in the general population (2.8% vs
.1%–0.2%), but lower than that previously shown in heart
ransplant patients (5%–14%).9,22,23 The etiology of CAF
in heart transplant patients remains unclear. Some workers
consider that trauma produced by repeat EMBs is the cause
for the development of CAF.9,22,24 The presence of dilated
arterioles in the histological specimens of transplanted
patients with CAF has confirmed this association. However,
a previous study found no difference in the number of EMB
procedures in transplant patients with versus without
CAF.25 Furthermore, in our population and also in another
arge study,9 patients who developed CAF did not show
ilated arterioles upon histological examinations. As previ-
usly described, the majority of CAF showed a benign
volution.26,27 The spontaneous closure of a fistula, ob-
served in one of our cases, may have been due to the
progression of the allograft coronary artery disease.
The several limitations of our study include its retrospec-
tive nature and the data being from a single heart trans-
plantation center. Transthoracic echocardiography was not
performed immediately before EMB, hence, we could notvaluate the development of small pericardial effusions as a
irect consequence of this procedure.
In conclusion, EMB proved to show high diagnostic
ccuracy to identify graft rejection among heart transplant
atients. The benefits derived from this invasive procedure
ere clearly superior to the risks. Serious complications
ere extremely rare. EMB can be performed with little or
o discomfort; it is a safe procedure.
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